{"entities":{"Q11017":{"pageid":16378,"ns":120,"title":"Item:Q11017","lastrevid":221998,"modified":"2020-06-22T14:40:37Z","type":"item","id":"Q11017","labels":{"en":{"language":"en","value":"HFSA/ACC/AHA, et al,  (Accessed April 1, 2020), cited as Ref 23 in DOI: 10.1007/s11886-020-01293-2"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty\" Curr Cardiol Rep; 2020 04 29 ; 22 (5) 34."}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q11017$A125C677-0CA3-4F63-9E9D-C5EDBDD8506D","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":10321,"id":"Q10321"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q11017$A7F13449-B991-4753-BC81-DDF3809B3AD9","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"HFSA/ACC/AHA Joint Statement addressing concerns re: using RAAS antagonists in COVID-19.","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q11017$B19F9E2E-DEB1-49E8-B15C-A5C609734DC9","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2020-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q11017$9FCD7EDD-A2F0-4E4A-9EE7-748DA129451D","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"HFSA/ACC/AHA","type":"string"},"datatype":"string"},"type":"statement","id":"Q11017$C860B568-367F-4D18-B568-E66CF2E17B32","rank":"normal"}],"P92":[{"mainsnak":{"snaktype":"value","property":"P92","datavalue":{"value":"https://www.hfsa.org/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician/","type":"string"},"datatype":"url"},"type":"statement","id":"Q11017$30cf72cd-41ae-dab0-0e82-c9168f1975d0","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"HFSA/ACC/AHA, et al, (Accessed April 1, 2020), cited as Ref 23 in DOI: 10.1007/s11886-020-01293-2","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/HFSA/ACC/AHA,_et_al,_(Accessed_April_1,_2020),_cited_as_Ref_23_in_DOI:_10.1007/s11886-020-01293-2"}}}}}